This site is fully related to medical laboratory information for public and health care professionals.
Introduction The Xpert MTB/RIF assay is an automated, cartridge-based molecular test used to detect Mycobacterium tuberculosis (MTB) and rifampicin (RIF) resistance, the most potent first-line anti-TB drug. Endorsed by the WHO in 2010, the Xpert MTB/RIF assay revolutionized TB diagnosis by providing results in less than two …
Introduction Xpert MTB/RIF Ultra is an automated diagnostic test designed for the rapid and simultaneous detection of Mycobacterium tuberculosis (MTB) and resistance to rifampin (RIF). It is a second-generation assay developed by Cepheid to provide significantly higher sensitivity than the original Xpert MTB/RIF, particularly for …
Introduction The Xpert MTB/XDR assay is an advanced molecular diagnostic tool designed by Cepheid to rapidly detect Mycobacterium tuberculosis complex (MTBC) and its resistance to multiple first- and second-line drugs. Launched in 2021, it is categorized as a “low complexity” automated nucleic acid amplification test …
Introduction & Taxonomy Aspergillus terreus is a filamentous fungus increasingly recognized as a significant emerging opportunistic pathogen. It is uniquely distinguished from other common species by its intrinsic resistance to amphotericin B, its characteristic cinnamon-brown colony color, and the production of specialized spores called aleurioconidia. …
Introduction In today’s rapidly evolving healthcare landscape, the demand for fast, accurate, and accessible diagnostic tools has never been greater. Molecular diagnostics, particularly PCR-based testing, has become the gold standard for detecting infectious diseases. At the forefront of this transformation is Bioeksen—a company redefining how …
The increasing burden of infectious diseases demands diagnostic solutions that are not only rapid but also highly sensitive and comprehensive. Conventional diagnostic methods often fall short due to time delays and limited pathogen coverage. In this context, multiplex real-time PCR technologies are revolutionizing infectious disease …
Fungal infections represent a growing global health challenge, causing over 1.7 million deaths annually, with nearly 75% of cases remaining undiagnosed or diagnosed too late. The increasing burden of antifungal resistance (AMR) further complicates treatment outcomes, highlighting an urgent need for rapid, accurate, and comprehensive …
Introduction TrueNat is a rapid, chip-based, and portable molecular diagnostic test. It is developed by Molbio Diagnostics for the detection of tuberculosis (TB) and rifampicin (RIF) resistance. It is the first molecular point-of-care test for TB recommended by the World Health Organization (WHO). Principle The TrueNat system …